About Us

Years of Experience Years of Experience

18+

About Caerus Global Pty Ltd

At Caerus Global Pty Ltd, we stand as a beacon of expertise and innovation in the dynamic field of Pharmacovigilance. With a distinguished career spanning over 18 years, our Founder and Managing Director brings a wealth of diverse experience, serving as a seasoned expert in the pharmaceutical industry.

Our Journey

Leveraging over 14 years of profound expertise in the Pharmacovigilance domain, our Founder and Managing Director has been instrumental in shaping the industry landscape. Despite Caerus Global Pty Ltd being a relatively new entrepreneurial venture, having been registered in New South Wales, Australia just two years ago, our impact and vision resonates deeply. Our footprint extends across major pharmaceutical entities, including Eli Lilly, Novartis, GSK, Viatris, Valneva, Novavax, Haleon, Samsung Bioepis, and regulatory authority MHRA.

Our Vision

We aspire to become a global leader in pharmacovigilance software development, offering not only top-quality tools but also actively supporting our clients in achieving their patient safety goals through continuous innovation and improvement.

Leadership in Action

As the visionary Founder and Managing Director of Caerus Global, our leader has spearheaded techno-functional services that redefine the intersection of technology and Pharmacovigilance. In collaboration with our partner, we proudly implemented the Signal Management solution system for a South Korean based biotechnology company, showcasing our commitment to excellence.

Innovation in Progress

Currently, in collaboration with partners, we are actively engaged in implementing advanced signal management solutions for Tier 1 pharmaceutical company and the an esteemed health regulatory authority. Our dedication to pioneering solutions is further underscored by our work on a revolutionary software solution for Medical Devices signal management, aimed at pushing the boundaries of industry standards.

Proprietary Excellence

At the heart of Caerus Global’ s commitment to innovation lies ConvertPV, a proprietary product – ICSR E2B R2 to R3 report conversion tool. This tool, conceived and developed within our organization, serves as a guiding light for pharmaceutical companies and regulators navigating the complex transition to R3 standards for electronic report submission.

A Vision for Advancement

Driven by an unwavering passion for advancing Pharmacovigilance, our leader continues to steer Caerus Global towards new horizons. Through innovative initiatives, we ensure seamless transitions to evolving industry standards, contributing significantly to the evolution of pharmaceutical safety practices.

Embark on a journey with Caerus Global Pty Ltd, where expertise meets innovation, and together, we shape the future of Pharmacovigilance.